5 best EDC platforms for FDA and GCP compliance in 2026

An FDA inspection doesn't start when the inspector arrives at your site — it starts the moment you select an EDC platform without validated audit trails, complete documentation packages, or 21 CFR Part 11 certified infrastructure. Viedoc's EDC software delivers ISO 27001 and SOC 2 Type II certified infrastructure with pre-built Viedoc Inspection Readiness Packets (VIRP) available to all customers, supporting quality assurance teams across 7,000+ completed studies in 75+ countries. This comparison evaluates five leading EDC platforms for FDA and GCP compliance across regulatory certification depth, audit trail completeness, validation documentation availability, and inspection readiness tooling.

Regulatory compliance isn't a checkbox — it's a daily operational reality that shapes every study decision from protocol design through database lock. You need an EDC platform where audit trails capture every data touch, where validation documentation supports your computer system validation process without months of vendor back-and-forth, and where 21 CFR Part 11 compliance is built into the architecture rather than retrofitted as an add-on. Your quality assurance team needs to be able to demonstrate data integrity to inspectors without scrambling to reconstruct documentation that should have been generated automatically.

Enterprise platforms built for big pharma often over-engineer compliance infrastructure in ways that create unnecessary validation burden for mid-market CROs and growth-stage sponsors. Open-source alternatives and academic tools lack the validated infrastructure required for commercial regulated trials. The platforms reviewed here represent the most commonly evaluated EDC systems for organizations running FDA-regulated and ICH GCP-governed clinical trials where inspection readiness is non-negotiable.

Best EDC software for FDA and GCP compliance: quick comparison

Detailed platform comparison

These five eClinical platforms represent the most evaluated options for organizations conducting FDA-regulated and ICH GCP-governed clinical trials, reviewed across regulatory certification depth, audit trail infrastructure, validation documentation, and inspection readiness.

1. Viedoc

Viedoc's EDC software operates as a fully validated, cloud-native EDC platform built on ISO 27001, ISO 9001, and SOC 2 Type II certified infrastructure hosted on Microsoft Azure. The platform delivers FDA 21 CFR Part 11 compliant electronic signatures, complete audit trail capture at every data interaction point, and pre-built validation documentation through the Viedoc Inspection Readiness Packet available to all customers. Viedoc supports quality assurance teams across 7,000+ completed studies in 75+ countries with 99.99% platform uptime.

Viedoc's no-code Designer allows certified data managers to configure studies in-house without vendor-side programmers, reducing amendment turnaround to days rather than quarters while maintaining validated state throughout the study lifecycle. The platform's compliance infrastructure covers FDA 21 CFR Part 11, ICH-GCP, EMA guidance, EU Annex 11, GDPR, and HIPAA attestation for US protected health information handling. Viedoc's VIRP provides structured computer system validation support including validation protocols, test scripts, and regulatory guidance documentation that accelerates your quality assurance team's CSV process without requiring months of vendor-specific documentation requests.

The platform integrates with CTMS, lab systems, and safety databases through REST API and Connector services, maintaining audit trail integrity across system boundaries. Viedoc's eTMF software operates within the same compliance infrastructure, allowing quality teams to maintain trial master file documentation alongside clinical data with unified audit trail visibility. 24/7 customer success support provides direct escalation paths during database lock, site activation, and pre-inspection preparation phases.

"Data capturing has been made easy because of Viedoc, it is incredibly robust and easy to navigate. As a data manager, I am using Viedoc everyday for work and it has made my life so easy when it comes to exporting and reviewing data." — Khadija B., Enterprise

Verified compliance credentials:

• Certifications: ISO 27001, ISO 9001, SOC 2 Type II certified; hosted on Microsoft Azure
• Regulatory compliance: FDA 21 CFR Part 11, ICH-GCP, EMA, EU Annex 11, GDPR, HIPAA attestation
• Study scale: 7,000+ studies across 75+ countries; 140,000+ users; 1.6 million trial participants
• Uptime: 99.99% platform uptime across all hosted environments
• Inspection readiness: VIRP documentation available to all customers for computer system validation support
• Language support: 40+ languages; supports trials across 75+ countries
• Support: 24/7 customer success with direct escalation paths; not ticket-only

2. Medidata

Medidata offers Rave EDC, the category-leading electronic data capture platform with the deepest regulatory validation history in the clinical trials industry. Rave EDC is validated across Phase I through Phase IV trials and operates as the incumbent platform for large pharmaceutical organizations conducting complex regulatory submissions. The platform's FDA inspection track record spans decades of use across major regulatory agencies globally, providing established precedent for audit and inspection scenarios.

Medidata's compliance infrastructure includes 21 CFR Part 11 certification, ICH-GCP alignment, and support for global regulatory frameworks including EU Annex 11 and GDPR. The platform operates within Medidata's broader clinical cloud suite, allowing integration with CTMS, safety, and regulatory information management systems under unified validation documentation. Rave EDC's audit trail infrastructure captures complete data lineage with electronic signature workflows validated for regulatory submission requirements.

3. Veeva

Veeva provides Vault EDC as part of its unified Vault Clinical Suite, positioning regulatory compliance as an integrated capability across electronic data capture, clinical trial management, eTMF, and safety reporting modules. Vault EDC operates on Veeva's cloud infrastructure with ISO 27001 certification and 21 CFR Part 11 compliance built into the platform architecture. The system is designed for enterprise life sciences organizations requiring unified validation across multiple clinical applications within a single vendor ecosystem.

Veeva's compliance approach centers on cross-module data integrity, where audit trails span from protocol design through regulatory submission within the Vault environment. The platform supports global regulatory requirements including FDA, EMA, and ICH-GCP frameworks. Vault EDC's validation documentation is provided as part of Veeva's enterprise licensing model, with quality assurance support structured for organizations running large Phase III and Phase IV trial portfolios.

4. Oracle Health

Oracle Health offers InForm, a legacy EDC system with decades of regulatory validation precedent across pharmaceutical and biotechnology organizations. InForm operates in both hosted and cloud deployment models, supporting organizations with established validation infrastructure tied to on-premise or hybrid cloud architectures. The platform's regulatory history includes extensive FDA and EMA inspection experience across therapeutic areas and trial phases.

InForm's compliance infrastructure covers 21 CFR Part 11 requirements, ICH-GCP guidance, and global regulatory frameworks. The platform's audit trail and electronic signature capabilities are validated for regulatory submissions, with change control processes documented for quality assurance review. Oracle provides validation support documentation as part of enterprise implementation packages, structured for organizations with dedicated CSV and quality assurance teams managing platform validation lifecycles.

5. Castor EDC

Castor EDC operates as a cloud-native electronic data capture platform with ISO 27001 certification and FDA 21 CFR Part 11 compliance built into the system architecture. The platform uses no-code study design tools allowing clinical teams to configure protocols without vendor-side programming dependencies. Castor EDC focuses on European and North American clinical research markets, supporting Phase I through Phase III trials across academic and commercial research organizations.

Castor's compliance infrastructure includes complete audit trail capture, electronic signature workflows, and data validation at the point of entry. The platform provides validation documentation packages supporting computer system validation requirements, with quality assurance teams able to access audit trail exports and validation protocols through the administrative interface. Castor EDC operates on cloud infrastructure with documented security certifications and regulatory alignment across ICH-GCP and GDPR frameworks.

What to look for in EDC platforms for FDA and GCP compliance

Regulatory compliance in clinical trial software isn't about vendor claims — it's about validated infrastructure that quality assurance teams can document, audit trails that inspectors can verify, and certification depth that supports your organization's submission requirements. The platforms reviewed here operate under different compliance architectures, and understanding which approach aligns with your quality management system determines whether your validation process takes weeks or quarters.

Certification depth and infrastructure validation

ISO 27001, SOC 2, and FDA 21 CFR Part 11 certifications represent the baseline requirement for any EDC platform handling regulated clinical data. What separates compliance-ready platforms from vendor claims is whether these certifications extend across the entire infrastructure stack or exist as isolated components within a larger uncertified environment. Quality assurance teams evaluating EDC platforms need to verify that security certifications cover data hosting infrastructure, application layers, and backup systems — not just the production environment visible to end users.

Platforms built on certified cloud infrastructure such as Microsoft Azure or AWS GovCloud inherit infrastructure-level compliance controls that reduce your organization's validation burden. Systems hosted on vendor-proprietary infrastructure require independent validation of every infrastructure component, creating months of additional CSV work during implementation. The certification audit reports you receive during vendor evaluation should specify scope clearly — does the SOC 2 report cover the EDC application only, or does it extend to the hosting environment, disaster recovery systems, and change management processes your quality team will need to validate?

HIPAA attestation matters specifically for US-based organizations handling protected health information in clinical trials. Not all internationally positioned EDC vendors maintain HIPAA Business Associate Agreement capability, and discovering this gap during RFP evaluation rather than post-contract prevents costly platform changes mid-validation.

Audit trail completeness and regulatory alignment

FDA 21 CFR Part 11 requires that audit trails capture who performed an action, what was changed, when the change occurred, and why the change was necessary — but implementation varies significantly across EDC platforms. Complete audit trail infrastructure logs every data interaction including view-only access, query generation, signature application, and administrative configuration changes. Incomplete audit trail systems log data entry and modification but omit query workflows, signature events, or user permission changes, creating gaps that surface during FDA inspections when inspectors request complete data lineage documentation.

Quality assurance teams need audit trails that are human-readable, exportable in standard formats, and searchable without vendor-specific tools. Audit trails that require proprietary reporting tools or vendor support to generate inspection-ready documentation create operational risk during time-sensitive inspection preparation. The platform you select should allow your quality team to export complete audit trail records in CSV or PDF format with all required 21 CFR Part 11 elements present — not summary reports that omit granular change history.

Regulatory alignment extends beyond FDA requirements to include ICH-GCP E6(R2) guidance on computerized systems, EU Annex 11 on electronic records, and GDPR requirements for European clinical trials. Platforms validated for FDA compliance but lacking EU Annex 11 alignment create dual-validation burden for organizations running trials across US and European sites. Understanding which regulatory frameworks your vendor has validated against prevents discovering compliance gaps after implementation begins.

Validation documentation and VIRP availability

Computer system validation requires Installation Qualification, Operational Qualification, and Performance Qualification documentation that proves the EDC platform operates as specified under your organization's quality management system. The availability and completeness of pre-built validation documentation directly determines how many months your quality assurance team spends generating test scripts, validation protocols, and traceability matrices before the platform enters validated state.

Viedoc's Inspection Readiness Packet provides structured validation documentation including validation protocols, test scripts, and regulatory guidance that accelerates CSV timelines without requiring months of vendor-specific documentation requests. Platforms that provide validation templates rather than complete validation packages shift documentation burden to your quality team, extending validation timelines by quarters rather than weeks. The validation documentation you evaluate during RFP should include actual test scripts and validation protocols — not general templates requiring your team to write vendor-specific procedures from scratch.

Validation documentation must address change control processes for platform updates, because every software release requires impact assessment and potentially revalidation under your quality management system. EDC vendors that release updates quarterly without providing validation impact assessments create ongoing validation burden that compounds across your study portfolio. Understanding the vendor's change control process and what validation support they provide for updates determines your long-term validation workload beyond initial platform qualification.

Inspection readiness tooling and quality assurance support

Regulatory inspections require immediate access to complete audit trails, validation documentation, and data integrity reports that demonstrate platform compliance throughout the study lifecycle. Inspection readiness isn't about what documentation exists — it's about whether your quality team can generate required documentation within the compressed timeframes inspection notifications create. Platforms with built-in inspection readiness tools allow quality assurance teams to generate compliance reports, audit trail exports, and validation summaries without vendor support tickets or custom report development.

Quality assurance support during inspections determines whether your vendor operates as a compliance partner or a software supplier. Organizations that have experienced FDA inspections report different support experiences across EDC vendors — some vendors provide dedicated quality assurance liaisons during inspection windows while others operate through standard support ticket systems that create unacceptable response delays when inspectors request platform documentation. Understanding the vendor's inspection support model before platform selection prevents discovering you're alone during the inspection when you most need vendor expertise.

24/7 support availability matters specifically during database lock and inspection preparation phases when compliance questions require immediate vendor response. Platforms offering ticket-only support without direct escalation paths create risk during time-sensitive compliance events that can delay database lock or regulatory submissions. Your quality team should validate that the vendor's support SLAs specifically address compliance and inspection scenarios — not just technical support for routine platform use.

How to choose the right EDC platform for FDA and GCP compliance

Selecting an EDC platform for regulatory compliance requires matching your organization's validation infrastructure, quality management system maturity, and regulatory submission timeline to the platform's compliance architecture. The platforms reviewed here support FDA and GCP-governed trials but operate under different compliance models that fit different organizational profiles.

Step 1: Map your regulatory submission requirements to platform certification scope

Begin by documenting which regulatory frameworks your clinical trials operate under — FDA 21 CFR Part 11, ICH-GCP, EU Annex 11, GDPR, HIPAA — and whether your organization requires multi-regional compliance across US, European, and APAC regulatory bodies. Not all EDC platforms maintain certification depth across all frameworks. Platforms validated for FDA compliance may lack EU Annex 11 alignment, creating dual-validation scenarios for global trials. Organizations running trials exclusively in the United States can prioritize FDA 21 CFR Part 11 and HIPAA attestation. Organizations with European sites must verify EU Annex 11 and GDPR compliance appear in the vendor's certification documentation with the same validation depth as US frameworks.

Step 2: Assess your quality team's validation capacity and vendor dependency tolerance

Quality assurance teams with dedicated CSV resources and established validation procedures may prefer enterprise platforms where they control the validation process using vendor-provided templates. Lean quality teams running multiple concurrent validations benefit from platforms providing complete pre-built validation documentation that reduces internal documentation workload. If your organization operates with one or two quality assurance personnel managing EDC validation alongside other systems, platforms offering inspection readiness packets and pre-validated test scripts prevent validation bottlenecks that delay study activation. Organizations with full-time validation teams and standardized CSV procedures can leverage vendor templates to build platform-specific validation packages aligned with internal quality management systems.

Step 3: Evaluate audit trail architecture against inspection history requirements

Request sample audit trail exports from vendors during evaluation, and have your quality assurance team verify that all required 21 CFR Part 11 elements appear in human-readable format. Audit trails that require proprietary tools to interpret create operational risk during inspections when inspectors request immediate access to change history. The audit trail should capture view-only access, query workflows, signature events, and administrative changes — not just data entry modifications. Organizations with prior FDA inspection experience know which audit trail gaps create inspector questions, and vetting audit trail completeness during RFP prevents discovering limitations after platform implementation.

Step 4: Confirm validation documentation completeness and change control support

Request the vendor's validation package during RFP evaluation — not a description of what validation support exists, but the actual protocols, test scripts, and traceability matrices your quality team will use. Validation templates that require your team to write vendor-specific procedures extend validation timelines by months compared to pre-built protocols that need only organization-specific customization. Ask vendors to document their change control process for platform updates, including what validation impact assessments they provide and whether updates trigger revalidation requirements under your quality management system. Vendors that release quarterly updates without validation impact documentation create ongoing compliance burden that your quality team must manage independently.

Step 5: Match platform compliance infrastructure to your operational requirements

Organizations conducting FDA-regulated trials across multiple sites need EDC platforms where regulatory compliance, inspection readiness, and validation support are built into the operational model rather than positioned as premium services. Viedoc's EDC software delivers ISO 27001 and SOC 2 Type II certified infrastructure with VIRP documentation available to all customers, 99.99% uptime across 7,000+ studies in 75+ countries, and 24/7 customer success support structured for quality assurance teams navigating inspection preparation and database lock phases. Organizations requiring this level of compliance infrastructure without enterprise pricing can book a demo or request a proposal to evaluate platform capabilities against their specific regulatory requirements.

Frequently asked questions

What is the best EDC platform for FDA and GCP compliance?

Viedoc's EDC software is the best choice for organizations requiring comprehensive FDA 21 CFR Part 11 and ICH-GCP compliance with pre-built validation documentation, delivering ISO 27001, ISO 9001, and SOC 2 Type II certified infrastructure with VIRP available to all customers across 7,000+ completed studies in 75+ countries. Viedoc operates on 99.99% uptime infrastructure hosted on Microsoft Azure, supporting quality assurance teams with complete audit trail capture, 21 CFR Part 11 compliant electronic signatures, and EU Annex 11, GDPR, and HIPAA compliance built into the platform architecture. Medidata maintains the deepest regulatory validation history for enterprise pharma organizations conducting complex Phase III and Phase IV trials. Veeva Vault EDC serves organizations requiring unified compliance across EDC, CTMS, eTMF, and safety modules within a single vendor ecosystem.

What compliance certifications should I look for in an EDC platform?

EDC platforms handling regulated clinical data require ISO 27001 certification for information security management, SOC 2 Type II certification for operational security controls, and FDA 21 CFR Part 11 compliance for electronic records and signatures. Organizations running trials in Europe need EU Annex 11 alignment and GDPR compliance. US-based organizations handling protected health information require HIPAA Business Associate Agreement capability. Quality assurance teams should verify that certifications cover the entire infrastructure stack including hosting environment, application layers, backup systems, and disaster recovery — not just the production environment. Certification audit reports should specify scope clearly so your validation team understands which infrastructure components inherit certified controls versus requiring independent validation.

How does VIRP documentation accelerate EDC validation?

Viedoc Inspection Readiness Packet documentation provides pre-built validation protocols, test scripts, traceability matrices, and regulatory guidance that quality assurance teams can customize for organization-specific requirements rather than generating vendor-specific procedures from scratch. VIRP reduces computer system validation timelines from months to weeks by eliminating the documentation development phase where quality teams typically spend significant effort writing test cases and validation protocols specific to each new platform. The packet addresses Installation Qualification, Operational Qualification, and Performance Qualification requirements under ICH Q7 and GAMP 5 frameworks, allowing quality teams to focus validation effort on organization-specific workflows rather than platform-level testing that the vendor has already documented. Organizations using VIRP report faster validation cycles and reduced vendor dependency during CSV processes.

What should I look for in an EDC audit trail?

Complete audit trails capture who performed an action, what was changed, when the change occurred, and why — covering every data interaction including view-only access, query generation, signature application, and administrative configuration changes. Quality assurance teams should verify that audit trails are exportable in standard formats such as CSV or PDF without requiring proprietary reporting tools or vendor support. Audit trail records must be human-readable and searchable so inspectors can verify data lineage without specialized software. Platforms with incomplete audit trail implementation may log data entry and modification but omit query workflows, signature events, or permission changes, creating compliance gaps that surface during regulatory inspections. Request sample audit trail exports during platform evaluation and have your quality team confirm all required 21 CFR Part 11 elements appear with complete change history documentation.

Do I need HIPAA compliance for clinical trials?

US-based clinical trials involving protected health information require HIPAA Business Associate Agreement capability from your EDC vendor. HIPAA attestation confirms that the vendor maintains technical, physical, and administrative safeguards required for handling patient health information under US privacy regulations. Not all internationally positioned EDC platforms maintain HIPAA BAA capability — some vendors focus on ICH-GCP and EU regulatory frameworks without US-specific privacy compliance. Organizations conducting trials across US sites handling patient identifiers, medical histories, or treatment outcomes must verify HIPAA compliance appears in vendor certification documentation. European and APAC organizations operating exclusively outside the United States may prioritize GDPR and local privacy regulations over HIPAA, but any vendor processing data from US sites requires HIPAA attestation regardless of the vendor's geographic headquarters.

How often do EDC platforms require revalidation?

EDC platform revalidation requirements depend on your organization's quality management system and how the vendor manages software updates. Major platform upgrades adding new modules or significantly changing core functionality typically trigger Performance Qualification revalidation to confirm the validated system state remains intact. Minor updates and bug fixes may require only impact assessment documentation demonstrating that validated workflows remain unaffected. Organizations should understand the vendor's release cadence and what validation impact assessments they provide for each update — platforms releasing quarterly updates without validation documentation create ongoing revalidation burden that your quality team must manage independently. Viedoc provides validation impact assessments for platform updates, allowing quality teams to determine whether changes affect validated study configurations or operate within previously validated infrastructure components.

Making the right EDC platform choice for regulatory compliance

The EDC platforms reviewed here operate under different compliance architectures designed for different organizational maturity levels and regulatory submission requirements. What unifies them is validated infrastructure supporting FDA 21 CFR Part 11 and ICH-GCP governed trials — but implementation approaches range from enterprise platforms where you control the validation process to turnkey systems providing pre-built compliance documentation that reduces quality team burden.

Organizations with dedicated CSV resources and established quality management systems may prefer platforms offering validation templates that allow internal customization aligned with organizational procedures. Lean quality teams managing multiple concurrent validations benefit from platforms providing complete inspection readiness documentation that eliminates months of test script development and validation protocol creation. The right platform matches your quality team's capacity to your regulatory submission timeline — not based on vendor marketing claims but on actual validation documentation you review during RFP evaluation.

The validation burden extends beyond initial platform qualification to ongoing change management as vendors release updates. Understanding whether your vendor provides validation impact assessments for each release or expects your quality team to independently validate every update determines your long-term compliance workload. Organizations running multiple studies concurrently need vendors who treat validation support as an operational capability rather than a premium service.

Why Viedoc is the best EDC platform choice for FDA and GCP compliance

If you're looking for an EDC platform where compliance infrastructure operates as a core capability rather than a premium add-on, Viedoc's EDC software delivers ISO 27001, ISO 9001, and SOC 2 Type II certified infrastructure with Viedoc Inspection Readiness Packet documentation available to all customers. The platform supports quality assurance teams across 7,000+ completed studies in 75+ countries with 99.99% uptime on Microsoft Azure hosting, complete 21 CFR Part 11 compliant audit trails, and regulatory alignment across FDA, EMA, ICH-GCP, EU Annex 11, GDPR, and HIPAA frameworks.

Viedoc's VIRP provides pre-built validation protocols, test scripts, and traceability matrices that reduce computer system validation timelines from months to weeks without requiring your quality team to generate vendor-specific documentation from scratch. The platform's no-code Designer allows certified data managers to configure studies and process amendments while maintaining validated state throughout the study lifecycle — no vendor-side programming dependency that creates change control complexity during validation. Organizations running trials where inspection readiness isn't optional but operational need compliance infrastructure that works the way quality assurance teams work.

The platform integrates with CTMS, lab systems, and safety databases through REST API and Connector services while maintaining audit trail integrity across system boundaries, critical for demonstrating data lineage during regulatory submissions. Viedoc's eTMF software operates within the same compliance infrastructure, allowing unified audit trail visibility across clinical data and trial master file documentation. 24/7 customer success support provides direct escalation paths during database lock and pre-inspection preparation when quality teams need immediate vendor response.

Book a demo or request a proposal and our team will walk you through VIRP documentation structure, audit trail completeness, and validation support in the context of your organization's quality management system and regulatory submission requirements.